;PMID: 9065402
;source_file_521.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..38] = [t:0..38]
;1)section:[e:43..54] = [t:43..54]
;2)section:[e:57..95] = [t:57..95]
;3)sentence:[e:99..193] = [t:99..193]
;4)section:[e:197..275] = [t:197..275]
;5)section:[e:279..395] = [t:279..395]
;6)sentence:[e:399..506] = [t:399..506]
;7)sentence:[e:507..691] = [t:507..691]
;8)sentence:[e:692..808] = [t:692..808]
;9)sentence:[e:809..983] = [t:809..983]
;10)sentence:[e:984..1175] = [t:984..1175]
;11)section:[e:1179..1223] = [t:1179..1223]

;section 0 Span:0..38
;Science  1997 Mar 21;275(5307):1787-90
(SEC
  (FRAG (NNP:[0..7] Science) (CD:[9..13] 1997) (NNP:[14..17] Mar)
        (CD:[18..20] 21) (CD:[20..29] ;275-LRB-5307) (CD:[29..30] -RRB-)
        (CD:[30..35] :1787) (HYPH:[35..36] -) (CD:[36..38] 90)))

;section 1 Span:43..54
;Comment in:
(SEC
  (FRAG (NN:[43..50] Comment) (IN:[51..53] in) (NN:[53..54] :)))

;section 2 Span:57..95
;Science. 1997 Mar 21;275(5307):1752-3.
(SEC
  (FRAG (NN:[57..64] Science) (IN:[64..65] .) (CD:[66..70] 1997)
        (NNP:[71..74] Mar) (CD:[75..77] 21) (CD:[77..86] ;275-LRB-5307)
        (CD:[86..87] -RRB-) (CD:[87..92] :1752) (HYPH:[92..93] -)
        (CD:[93..94] 3) (.:[94..95] .)))

;sentence 3 Span:99..193
;Activation of beta-catenin-Tcf signaling in colon cancer by mutations in 
;beta-catenin or APC.
;[113..125]:gene-generic:"beta-catenin"
;[126..129]:gene-generic:"Tcf"
;[143..155]:malignancy:"colon cancer"
;[173..185]:gene-rna:"beta-catenin"
;[189..192]:gene-rna:"APC"
(SENT
  (NP-HLN
    (NP (NN:[99..109] Activation))
    (PP (IN:[110..112] of)
      (NP
        (NML (NN:[113..125] beta-catenin) (HYPH:[125..126] -)
             (NN:[126..129] Tcf))
        (NN:[130..139] signaling)))
    (PP (IN:[140..142] in)
      (NP (NN:[143..148] colon) (NN:[149..155] cancer)))
    (PP-MNR (IN:[156..158] by)
      (NP
        (NP (NNS:[159..168] mutations))
        (PP-LOC (IN:[169..171] in)
          (NP (NN:[173..185] beta-catenin) (CC:[186..188] or)
              (NN:[189..192] APC)))))
    (.:[192..193] .)))

;section 4 Span:197..275
;Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler
;KW.
(SEC
  (FRAG (NNP:[197..202] Morin) (NNP:[203..205] PJ) (,:[205..206] ,)
        (NNP:[207..213] Sparks) (NNP:[214..216] AB) (,:[216..217] ,)
        (NNP:[218..225] Korinek) (NNP:[226..227] V) (,:[227..228] ,)
        (NNP:[229..235] Barker) (NNP:[236..237] N) (,:[237..238] ,)
        (NNP:[239..246] Clevers) (NNP:[247..248] H) (,:[248..249] ,)
        (NNP:[250..260] Vogelstein) (NNP:[261..262] B) (,:[262..263] ,)
        (NNP:[264..271] Kinzler) (NNP:[272..275] KW.)))

;section 5 Span:279..395
;Howard Hughes Medical Institute and Johns Hopkins Oncology Center, 424 North 
;Bond Street, Baltimore, MD 21231, USA.
(SEC
  (FRAG (NNP:[279..285] Howard) (NNP:[286..292] Hughes) (NNP:[293..300] Medical)
        (NNP:[301..310] Institute) (CC:[311..314] and) (NNP:[315..320] Johns)
        (NNP:[321..328] Hopkins) (NNP:[329..337] Oncology)
        (NNP:[338..344] Center) (,:[344..345] ,) (NNP:[346..349] 424)
        (NNP:[350..355] North) (NNP:[357..361] Bond) (NNP:[362..368] Street)
        (,:[368..369] ,) (NNP:[370..379] Baltimore) (,:[379..380] ,)
        (NNP:[381..383] MD) (CD:[384..389] 21231) (,:[389..390] ,)
        (NNP:[391..394] USA) (.:[394..395] .)))

;sentence 6 Span:399..506
;Inactivation of the adenomatous polyposis coli (APC) tumor suppressor gene 
;initiates colorectal neoplasia.
;[419..445]:gene-rna:"adenomatous polyposis coli"
;[447..450]:gene-rna:"APC"
;[485..505]:malignancy:"colorectal neoplasia"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[399..411] Inactivation))
      (PP (IN:[412..414] of)
        (NP (DT:[415..418] the)
          (NML
            (NML (JJ:[419..430] adenomatous) (NN:[431..440] polyposis)
                 (NN:[441..445] coli))
            (NML (-LRB-:[446..447] -LRB-) (NN:[447..450] APC)
                 (-RRB-:[450..451] -RRB-)))
          (NML (NN:[452..457] tumor) (NN:[458..468] suppressor))
          (NN:[469..473] gene))))
    (VP (VBZ:[475..484] initiates)
      (NP (JJ:[485..495] colorectal) (NN:[496..505] neoplasia)))
    (.:[505..506] .)))

;sentence 7 Span:507..691
;One of the biochemical activities associated  with the APC protein is
;down-regulation of transcriptional activation mediated  by beta-catenin and T
;cell transcription factor 4 (Tcf-4).
;[562..565]:gene-protein:"APC"
;[636..648]:gene-generic:"beta-catenin"
;[655..682]:gene-generic:"cell transcription factor 4"
;[684..689]:gene-generic:"Tcf-4"
(SENT
  (S
    (NP-SBJ
      (NP (CD:[507..510] One))
      (PP (IN:[511..513] of)
        (NP
          (NP (DT:[514..517] the) (JJ:[518..529] biochemical)
              (NNS:[530..540] activities))
          (VP (VBN:[541..551] associated)
            (NP (-NONE-:[551..551] *))
            (PP-CLR (IN:[553..557] with)
              (NP (DT:[558..561] the) (NN:[562..565] APC)
                  (NN:[566..573] protein)))))))
    (VP (VBZ:[574..576] is)
      (NP-PRD
        (NP
          (NP (RB:[577..581] down) (HYPH:[581..582] -)
              (NN:[582..592] regulation))
          (PP (IN:[593..595] of)
            (NP (JJ:[596..611] transcriptional) (NN:[612..622] activation))))
        (VP (VBN:[623..631] mediated)
          (NP (-NONE-:[631..631] *))
          (PP (IN:[633..635] by)
            (NP-LGS
              (NP (NN:[636..648] beta-catenin))
              (CC:[649..652] and)
              (NP
                (NP
                  (NML
                    (NML (NN:[653..654] T) (NN:[655..659] cell))
                    (NN:[660..673] transcription) (NN:[674..680] factor))
                  (CD:[681..682] 4))
                (NP (-LRB-:[683..684] -LRB-) (NN:[684..689] Tcf-4)
                    (-RRB-:[689..690] -RRB-))))))))
    (.:[690..691] .)))

;sentence 8 Span:692..808
;The protein products  of mutant APC genes present in colorectal tumors were
;found to be defective in  this activity.
;[696..712]:gene-protein:"protein products"
;[724..727]:gene-rna:"APC"
;[745..762]:malignancy:"colorectal tumors"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NP (DT:[692..695] The)
           (NN:[696..703] protein) (NNS:[704..712] products))
        (PP (IN:[714..716] of)
          (NP (JJ:[717..723] mutant) (NN:[724..727] APC) (NNS:[728..733] genes))))
      (ADJP (JJ:[734..741] present)
        (PP-LOC (IN:[742..744] in)
          (NP (JJ:[745..755] colorectal) (NNS:[756..762] tumors)))))
    (VP (VBD:[763..767] were)
      (VP (VBN:[768..773] found)
        (S
          (NP-SBJ-1 (-NONE-:[773..773] *))
          (VP (TO:[774..776] to)
            (VP (VB:[777..779] be)
              (ADJP-PRD (JJ:[780..789] defective))
              (PP (IN:[790..792] in)
                (NP (DT:[794..798] this) (NN:[799..807] activity))))))))
    (.:[807..808] .)))

;sentence 9 Span:809..983
;Furthermore, colorectal tumors with intact APC genes were found  to contain
;activating mutations of beta-catenin that altered functionally  significant
;phosphorylation sites.
;[822..839]:malignancy:"colorectal tumors"
;[852..855]:gene-rna:"APC"
;[909..921]:gene-rna:"beta-catenin"
(SENT
  (S
    (ADVP (RB:[809..820] Furthermore))
    (,:[820..821] ,)
    (NP-SBJ-1
      (NP (JJ:[822..832] colorectal) (NNS:[833..839] tumors))
      (PP (IN:[840..844] with)
        (NP (JJ:[845..851] intact) (NN:[852..855] APC) (NNS:[856..861] genes))))
    (VP (VBD:[862..866] were)
      (VP (VBN:[867..872] found)
        (S
          (NP-SBJ-1 (-NONE-:[872..872] *))
          (VP (TO:[874..876] to)
            (VP (VB:[877..884] contain)
              (NP
                (NP
                  (NP (VBG:[885..895] activating) (NNS:[896..905] mutations))
                  (PP (IN:[906..908] of)
                    (NP (NN:[909..921] beta-catenin))))
                (SBAR
                  (WHNP-2 (WDT:[922..926] that))
                  (S
                    (NP-SBJ-2 (-NONE-:[926..926] *T*))
                    (VP (VBD:[927..934] altered)
                      (NP
                        (ADJP (RB:[935..947] functionally)
                              (JJ:[949..960] significant))
                        (NN:[961..976] phosphorylation) (NNS:[977..982] sites)))))))))))
    (.:[982..983] .)))

;sentence 10 Span:984..1175
;These results indicate that regulation of  beta-catenin is critical to APC's
;tumor suppressive effect and that this  regulation can be circumvented by
;mutations in either APC or beta-catenin.
;[1027..1039]:gene-generic:"beta-catenin"
;[1055..1058]:gene-rna:"APC"
;[1155..1158]:gene-rna:"APC"
;[1162..1174]:gene-rna:"beta-catenin"
(SENT
  (S
    (NP-SBJ (DT:[984..989] These) (NNS:[990..997] results))
    (VP (VBP:[998..1006] indicate)
      (SBAR
        (SBAR (IN:[1007..1011] that)
          (S
            (NP-SBJ
              (NP (NN:[1012..1022] regulation))
              (PP (IN:[1023..1025] of)
                (NP (NN:[1027..1039] beta-catenin))))
            (VP (VBZ:[1040..1042] is)
              (ADJP-PRD (JJ:[1043..1051] critical)
                (PP (TO:[1052..1054] to)
                  (NP
                    (NP (NN:[1055..1058] APC) (POS:[1058..1060] 's))
                    (ADJP (NN:[1061..1066] tumor) (JJ:[1067..1078] suppressive))
                    (NN:[1079..1085] effect)))))))
        (CC:[1086..1089] and)
        (SBAR (IN:[1090..1094] that)
          (S
            (NP-SBJ-1 (DT:[1095..1099] this) (NN:[1101..1111] regulation))
            (VP (MD:[1112..1115] can)
              (VP (VB:[1116..1118] be)
                (VP (VBN:[1119..1131] circumvented)
                  (NP-1 (-NONE-:[1131..1131] *))
                  (PP-MNR (IN:[1132..1134] by)
                    (NP
                      (NP (NNS:[1135..1144] mutations))
                      (PP-LOC (IN:[1145..1147] in)
                        (NP (CC:[1148..1154] either) (NN:[1155..1158] APC)
                            (CC:[1159..1161] or) (NN:[1162..1174] beta-catenin))))))))))))
    (.:[1174..1175] .)))

;section 11 Span:1179..1223
;PMID: 9065402 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1179..1183] PMID) (::[1183..1184] :) (CD:[1185..1192] 9065402)
        (IN:[1193..1194] -LSB-) (NNP:[1194..1200] PubMed) (HYPH:[1201..1202] -)
        (JJ:[1203..1210] indexed) (IN:[1211..1214] for)
        (NNP:[1215..1223] MEDLINE-RSB-)))
